- Belgium-based- Nyxoah ( NASDAQ: NYXH ) said it signed a distribution agreement in Germany for AcuPebble SA100, a home sleep test for patients with Obstructive Sleep Apnea (OSA) developed by medical device company Acurable .
- Nyxoah added that AcuPebble is a next-generation wearable home sleep test which uses acoustic signals to diagnose OSA. The patient attaches the reusable AcuPebble sensor to the base of the neck to record sounds generated by the respiratory and cardiac functions which are then uploaded to a cloud platform via a smartphone application to provide an automated diagnostic report.
- Nyxoah expects to launch AcuPebble in Germany in Q4 2022.
For further details see:
Nyxoah inks distribution deal for Acurable's sleep test AcuPebble in Germany